Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Established Markets Growth (% cc) by Year
Established Markets Growth (% cc) (%)
Novartis Established Markets Growth (% cc): 7.0% in FY2025, down 4.0 pts from a year earlier.
Latest, FY2025
7.0%
Period ended Dec 31, 2025
Change on a year earlier
-4.0 pts
11.0% in FY2024
History
3 years
Since FY2023
Sources
3
Documents cited below
Where the FY2025 figure comes from
“|| Of which in established markets | 40 555 | 37 371 | 9 | 7 | 74 | 74”
Source: Novartis Form 6-K (0001114448-26-000007) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Established Markets Growth (% cc) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.0% | -4.0 pts | Novartis Form 6-K (0001114448-26-000007) ↗ |
| FY2024 | Dec 31, 2024 | 11.0% | +4.0 pts | Novartis Form 6-K (0001370368-25-000007) ↗ |
| FY2023 | Dec 31, 2023 | 7.0% | – | Novartis Form 6-K (0001370368-24-000007) ↗ |
Cite this data
StockData. (2026). Novartis Established Markets Growth (% cc) (%), annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-established-yoy-cc-pct
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.